Cortexyme shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Cortexyme
Tip: Access up to 7 years of quarterly data
All positions including Cortexyme held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cortexyme by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $770k | 230k | 3.35 |
| 2022-06-30 | $196k | 88k | 2.21 |
| 2022-03-31 | $381k | 62k | 6.19 |
| 2021-12-31 | $1.6M | 123k | 12.61 |
| 2021-09-30 | $4.2M | 46k | 91.70 |
| 2021-03-31 | $745k | 21k | 36.01 |
| 2020-12-31 | $1.3M | 49k | 27.78 |
| 2020-09-30 | $1.9M | 38k | 49.99 |
| 2020-06-30 | $1.8M | 39k | 46.36 |
| 2019-12-31 | $443k | 7.9k | 56.11 |
| 2019-09-30 | $201k | 8.1k | 24.94 |
| 2019-06-30 | $2.0M | 48k | 42.51 |